Mitogen-activated protein kinase kinase MEK6 and variants thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 13, 2000
Grant Date -
N/A
app pub date -
Dec 20, 1995
filing date -
Dec 20, 1995
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Compositions and methods are provide for potentiating the activity of the mitogen-activated protein kinase p38. In particular the mitogen-activated protein kinase kinase MEK6, and variants thereof that stimulate phosphorylation of p38 are provided. Such compounds may be used, for example, for therapy of diseases associated with the p38 cascade and to identify antibodies and other agents that inhibit or activate signal transduction via p38.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully